These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase. Lam HY Biochem Biophys Res Commun; 1984 Jan; 118(1):27-32. PubMed ID: 6320825 [TBL] [Abstract][Full Text] [Related]
7. "Spare" alpha 1-adrenergic receptors and the potency of agonists in rat vas deferens. Minneman KP; Abel PW Mol Pharmacol; 1984 Jan; 25(1):56-63. PubMed ID: 6143249 [TBL] [Abstract][Full Text] [Related]
8. Direct interaction of calmodulin antagonists with Ca2+/calmodulin-dependent cyclic nucleotide phosphodiesterase. Itoh H; Hidaka H J Biochem; 1984 Dec; 96(6):1721-6. PubMed ID: 6099352 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of the binding of phenoxybenzamine to calmodulin. Cimino M; Weiss B Biochem Pharmacol; 1988 Jul; 37(14):2739-45. PubMed ID: 3134891 [TBL] [Abstract][Full Text] [Related]
10. Investigation of the actions of chloroethylclonidine in rat aorta. O'Rourke M; Kearns S; Docherty JR Br J Pharmacol; 1995 Aug; 115(8):1399-406. PubMed ID: 8564198 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of calmodulin-stimulated cyclic nucleotide phosphodiesterase by the insecticide DDT. Hagmann J FEBS Lett; 1982 Jun; 143(1):52-4. PubMed ID: 6288452 [No Abstract] [Full Text] [Related]
12. Contractile actions of imidazoline alpha-adrenoceptor agonists and effects of noncompetitive alpha1-adrenoceptor antagonists in human vas deferens. Amobi N; Guillebaud J; Kaisary A; Lloyd-Davies RW; Turner E; Smith IC Eur J Pharmacol; 2003 Feb; 462(1-3):169-77. PubMed ID: 12591110 [TBL] [Abstract][Full Text] [Related]
13. The activation of brain adenylate cyclase and brain cyclic-nucleotide phosphodiesterase by seven calmodulin derivatives. Thiry P; Vandermeers A; Vandermeers-Piret MC; Rathe J; Christophe J Eur J Biochem; 1980 Jan; 103(2):409-14. PubMed ID: 6244945 [TBL] [Abstract][Full Text] [Related]
14. Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel. Ivorra MD; Lugnier C; Schott C; Catret M; Noguera MA; Anselmi E; D'Ocon P Br J Pharmacol; 1992 Jun; 106(2):387-94. PubMed ID: 1327380 [TBL] [Abstract][Full Text] [Related]
15. [Allosteric regulation of Ca2+-calmodulin-dependent phosphodiesterase activity from the bovine brain]. Bobruskin ID; Shaĭkhin SM; Muratova MV; Baranova LA; Severin ES Biokhimiia; 1987 Aug; 52(8):1344-52. PubMed ID: 2822149 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of activation of cyclic nucleotide phosphodiesterase: requirement of the binding of four Ca2+ to calmodulin for activation. Huang CY; Chau V; Chock PB; Wang JH; Sharma RK Proc Natl Acad Sci U S A; 1981 Feb; 78(2):871-4. PubMed ID: 6262778 [TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of calmodulin-sensitive phosphodiesterase and Ca++-adenosine triphosphatase by chlorpromazine-linked calmodulin. Prozialeck WC; Wallace TL; Weiss B J Pharmacol Exp Ther; 1987 Oct; 243(1):171-9. PubMed ID: 2822896 [TBL] [Abstract][Full Text] [Related]
18. Calmodulin-stimulated cyclic nucleotide phosphodiesterases in plasma membranes of bovine epididymal spermatozoa. Chaudhry PS; Casillas ER Arch Biochem Biophys; 1988 May; 262(2):439-44. PubMed ID: 2835007 [TBL] [Abstract][Full Text] [Related]
19. Alpha-adrenergic inhibition of cyclic AMP accumulation in hamster adipocytes. Similarity of receptor with alpha-2 adrenergic receptors. Schimmel RJ; Serio R; McMahon KK Biochim Biophys Acta; 1980 Nov; 632(4):544-52. PubMed ID: 6159928 [TBL] [Abstract][Full Text] [Related]
20. On the mechanism of activation of cyclic mucleotide phosphodiesterase by calmodulin. Wang JH; Sharma RK; Huang CY; Chau V; Chock PB Ann N Y Acad Sci; 1980; 356():190-204. PubMed ID: 6263147 [No Abstract] [Full Text] [Related] [Next] [New Search]